These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18186261)

  • 1. [Anti-steroid hormones for uterine cancer].
    Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
    Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiestrogen therapy of patients with uterine cancer].
    Sugimura M; Terao T
    Nihon Rinsho; 1994 Mar; 52(3):804-8. PubMed ID: 8164386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone therapy of endometrial carcinoma].
    Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R
    Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
    Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone therapy--recent advances].
    Matsumoto K; Noguchi S
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2816-23. PubMed ID: 2959202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
    Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
    Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New developments in hormonal therapy for breast cancer].
    Tominaga T
    Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
    Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM
    Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal therapy in endometrial cancer].
    Kanoh H; Okudaira Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2306-10. PubMed ID: 8259843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
    Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth of endometrial cancer and hormone].
    Kanoh H; Hosono T; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.